ipilimumab
bms
['melanoma']
tumor infiltrating lymphocytes (til) are immune cells found in tumors that can be expanded in the lab then reinfused into patients. this is the first randomized trial showing a benefit of #tiltherapy in patients with advanced #melanoma. #esmo22 
Moffitt Cancer Center President and CEO, @MoffittNews. Tumor immunologist. Inspired leader. Girl dad. #DocsWhoRock. Driven to save more lives from #cancer.